QL2302
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QL2302, covering 2025-12-24 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects [Phase 1]